Vistagen Therapeutics (VTGN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.20, -4.76% vs the prior close of $0.21.
- Volume 557.97K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
VTGN slides 4.8% to $0.20, a 52-week low, 12 down days in a row. Closed at $0.20, -4.76% vs the prior close of $0.21. Day range $0.20–$0.22, opened at $0.21.
VTGN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — VTGN slides 4.8% to $0.20, a 52-week low, 12 down days in a row
- Closed at $0.20, -4.76% vs the prior close of $0.21. Day range $0.20–$0.22, opened at $0.21.
- Volume was 557.97K shares, 0.0x its 50-day average of 13.12M — lighter than usual.
- Price is -21.1% vs its 50-day average ($0.25) and -57.6% vs its 200-day average ($0.47).
- 52-week range $0.20–$5.14; today's close sits at 0% of that range, 96.1% below the 52-week high.
- That makes 12 straight losses.
Oct 15, 2026 — VTGN ends flat (+0.0%) to $0.21, 11 down days in a row
- Closed at $0.21, +0.00% vs the prior close of $0.21. Day range $0.20–$0.22, opened at $0.21.
- Volume was 877.10K shares, 0.1x its 50-day average of 13.21M — lighter than usual.
- Price is -17.7% vs its 50-day average ($0.26) and -55.7% vs its 200-day average ($0.47).
- 52-week range $0.20–$5.14; today's close sits at 0% of that range, 95.9% below the 52-week high.
- That makes 11 straight losses.
Oct 14, 2026 — VTGN ends flat (+0.0%) to $0.21, 10 down days in a row
- Closed at $0.21, +0.00% vs the prior close of $0.21. Day range $0.20–$0.21, opened at $0.21.
- Volume was 983.20K shares, 0.1x its 50-day average of 15.55M — lighter than usual.
- Price is -18.3% vs its 50-day average ($0.26) and -55.9% vs its 200-day average ($0.48).
- 52-week range $0.20–$5.14; today's close sits at 0% of that range, 95.9% below the 52-week high.
- That makes 10 straight losses.
Oct 13, 2026 — VTGN slides 8.7% to $0.21, a 52-week low, 9 down days in a row
- Closed at $0.21, -8.70% vs the prior close of $0.23. Day range $0.21–$0.23, opened at $0.22.
- Volume was 1.03M shares, 0.1x its 50-day average of 15.54M — lighter than usual.
- Price is -18.9% vs its 50-day average ($0.26) and -56.1% vs its 200-day average ($0.48).
- 52-week range $0.20–$5.14; today's close sits at 0% of that range, 95.9% below the 52-week high.
- That makes 9 straight losses.
Oct 12, 2026 — VTGN slides 4.2% to $0.23, 8 down days in a row
- Closed at $0.23, -4.17% vs the prior close of $0.24. Day range $0.22–$0.24, opened at $0.24.
- Volume was 738.00K shares, 0.0x its 50-day average of 15.55M — lighter than usual.
- Price is -11.4% vs its 50-day average ($0.26) and -52.2% vs its 200-day average ($0.48).
- 52-week range $0.20–$5.14; today's close sits at 1% of that range, 95.5% below the 52-week high.
- That makes 8 straight losses.
Oct 9, 2026 — VTGN slides 4.0% to $0.24, 7 down days in a row
- Closed at $0.24, -4.00% vs the prior close of $0.25. Day range $0.24–$0.24, opened at $0.24.
- Volume was 403.30K shares, 0.0x its 50-day average of 15.56M — lighter than usual.
- Price is -7.6% vs its 50-day average ($0.26) and -50.4% vs its 200-day average ($0.48).
- 52-week range $0.20–$5.14; today's close sits at 1% of that range, 95.3% below the 52-week high.
- That makes 7 straight losses.
- SEC filings that day: 8-K.
Oct 8, 2026 — VTGN ends flat (+0.0%) to $0.25, 6 down days in a row
- Closed at $0.25, +0.00% vs the prior close of $0.25. Day range $0.24–$0.25, opened at $0.25.
- Volume was 959.10K shares, 0.1x its 50-day average of 15.56M — lighter than usual.
- Price is -3.8% vs its 50-day average ($0.26) and -48.6% vs its 200-day average ($0.49).
- 52-week range $0.20–$5.14; today's close sits at 1% of that range, 95.1% below the 52-week high.
- That makes 6 straight losses.
Oct 7, 2026 — VTGN ends flat (+0.0%) to $0.25, 5 down days in a row
- Closed at $0.25, +0.00% vs the prior close of $0.25. Day range $0.24–$0.26, opened at $0.25.
- Volume was 774.60K shares, 0.0x its 50-day average of 15.58M — lighter than usual.
- Price is -3.7% vs its 50-day average ($0.26) and -48.9% vs its 200-day average ($0.49).
- 52-week range $0.20–$5.14; today's close sits at 1% of that range, 95.1% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — VTGN slides 3.8% to $0.25, 4 down days in a row
- Closed at $0.25, -3.85% vs the prior close of $0.26. Day range $0.25–$0.27, opened at $0.27.
- Volume was 1.60M shares, 0.1x its 50-day average of 15.55M — lighter than usual.
- Price is -3.5% vs its 50-day average ($0.26) and -49.1% vs its 200-day average ($0.49).
- 52-week range $0.20–$5.14; today's close sits at 1% of that range, 95.1% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — VTGN slides 7.1% to $0.26, 3 down days in a row
- Closed at $0.26, -7.14% vs the prior close of $0.28. Day range $0.26–$0.28, opened at $0.28.
- Volume was 1.92M shares, 0.1x its 50-day average of 15.54M — lighter than usual.
- Price is +0.5% vs its 50-day average ($0.26) and -47.4% vs its 200-day average ($0.49).
- 52-week range $0.20–$5.14; today's close sits at 1% of that range, 94.9% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — VTGN ends flat (+0.0%) to $0.28
- Closed at $0.28, +0.00% vs the prior close of $0.28. Day range $0.28–$0.30, opened at $0.28.
- Volume was 1.25M shares, 0.1x its 50-day average of 15.54M — lighter than usual.
- Price is +8.4% vs its 50-day average ($0.26) and -45.6% vs its 200-day average ($0.51).
- 52-week range $0.20–$5.14; today's close sits at 2% of that range, 94.6% below the 52-week high.
VTGN latest news & SEC filings
Every SEC filing by or about VTGN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$13.03M (prior year -$15.10M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.30 (prior year -$0.47) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Jul 31, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Jul 31, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Jul 31, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade VTGN
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: Jun 15, 2026, Feb 12, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 7.33% (largest 48.0%). That is a volatile stock.
- Liquidity: about 31.55M shares (≈$6.31M) trade per day on average.
- 52-week position: $0.20 vs a range of $0.20–$5.14 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 9, 2026; 8-K Sep 25, 2026; 8-K Sep 24, 2026.
- Share count: 44.38M shares outstanding (Aug 10, 2026), +44.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
VTGN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.21 | 0.22 | 0.20 | 0.20 | 557.97K |
| Oct 15, 2026 | 0.21 | 0.22 | 0.20 | 0.21 | 877.10K |
| Oct 14, 2026 | 0.21 | 0.21 | 0.20 | 0.21 | 983.20K |
| Oct 13, 2026 | 0.22 | 0.23 | 0.21 | 0.21 | 1.03M |
| Oct 12, 2026 | 0.24 | 0.24 | 0.22 | 0.23 | 738.00K |
| Oct 9, 2026 | 0.24 | 0.24 | 0.24 | 0.24 | 403.30K |
| Oct 8, 2026 | 0.25 | 0.25 | 0.24 | 0.25 | 959.10K |
| Oct 7, 2026 | 0.25 | 0.26 | 0.24 | 0.25 | 774.60K |
| Oct 6, 2026 | 0.27 | 0.27 | 0.25 | 0.25 | 1.60M |
| Oct 5, 2026 | 0.28 | 0.28 | 0.26 | 0.26 | 1.92M |
| Oct 2, 2026 | 0.28 | 0.30 | 0.28 | 0.28 | 1.25M |
| Oct 1, 2026 | 0.31 | 0.31 | 0.28 | 0.28 | 2.03M |
| Sep 30, 2026 | 0.29 | 0.32 | 0.28 | 0.31 | 2.43M |
| Sep 29, 2026 | 0.29 | 0.30 | 0.28 | 0.30 | 2.03M |
| Sep 28, 2026 | 0.27 | 0.32 | 0.27 | 0.30 | 6.03M |
| Sep 25, 2026 | 0.28 | 0.30 | 0.26 | 0.27 | 5.57M |
| Sep 24, 2026 | 0.35 | 0.36 | 0.27 | 0.30 | 20.47M |
| Sep 23, 2026 | 0.39 | 0.55 | 0.34 | 0.37 | 574.96M |
| Sep 22, 2026 | 0.25 | 0.27 | 0.24 | 0.25 | 6.00M |
| Sep 21, 2026 | 0.24 | 0.24 | 0.23 | 0.23 | 332.10K |
About Vistagen Therapeutics
Vistagen Therapeutics (VTGN) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SOUTH SAN FRANCISCO, CA. State of incorporation: NV. Fiscal year ends March 31. SEC CIK 1411685.
VTGN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Paul R Edick | Director | Nov 4, 2025 |
| Shawn Singh | President and CEO | Jul 2, 2026 |
| Douglas J Williamson | Director | Jul 31, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Reid G. Adler | Chief Legal Officer | Jul 2, 2026 |
| Angel S Angelov | Chief Medical Officer | May 19, 2026 |
| Elissa S. Cote | Chief Corp Development Officer | Apr 9, 2026 |
| Joshua S. Prince | Chief Operating Officer | Apr 9, 2026 |
| Shawn Singh | President and CEO | Jul 2, 2026 |
| Nick B. Tressler | Chief Financial Officer | Jul 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
VTGN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Mar 31, 2026 | — | $-69.69M | -1.83 | $-66.44M |
| Mar 31, 2025 | — | $-51.42M | -1.67 | $-42.10M |
| Mar 31, 2024 | — | $-29.36M | -1.52 | $-25.81M |
| Mar 31, 2023 | $-227.00K | $-59.25M | -8.51 | $-49.72M |
| Mar 31, 2022 | $1.11M | $-47.76M | — | $-45.26M |
Latest balance sheet: total assets $35.74M, total liabilities $11.26M, cash $16.99M (as of Jun 30, 2026).
VTGN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $0.27 |
| Jun 15, 2026 | 8-K Item 2.02 (results) | $0.57 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $0.55 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $3.80 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $2.73 |
| Jun 17, 2025 | 8-K Item 2.02 (results) | $2.38 |
| Feb 13, 2025 | 8-K Item 2.02 (results) | $2.85 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $3.12 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| Jun 11, 2024 | 8-K Item 2.02 (results) | — |
| Feb 13, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on VTGN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.